Hill-rom

Spending by Year

Lobbying Firms

What They Lobby For

• Diabetic retinopathy.
• Medical Device excise tax repeal; taxation of medical technology; R & D tax credit; corporate tax reform.
• Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018.
• VA Procurement and payment reforms; prompt pay, veterans choice program issues, Care Veterans Deserve Act (H.R. 1152).
• Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2015 (H.R. 184/S. 108); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform, diabetic retinopathy; Extension of Continuing Appropriations Act of 2018; Bipartisan Budget Act of 2018.
• Medical Device excise tax repeal (H.R. 184); taxation of medical technology; R & D tax credit; corporate tax reform.
• Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018; H.R.6639 Diabetic Retinopothy Vision Loss and Blindness Prevention Act of 2018
• Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2015 (H.R. 184/S. 108); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform, H.R.6639 Diabetic retinopothy Vision Loss and Blindness Prevention Act of 2018; Extension of Continuing Appropriations Act of 2018; Bipartisan Budget Act of 2018.
• Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 184/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018; H.R.6639 Diabetic Retinopothy Vision Loss and Blindness Prevention Act of 2018
• VA Procurement and payment reforms; prompt pay, veterans choice program issues.

Related Investigations

Explore More